Moreover, the disruption of the intestinal barrier function by anti-CTLA4 treatment was found to be vital for the systemic translocation of adenosine derived from Bifidobacterium, consequently promoting Th1 activation and anti-tumor immunity via T cell-specific A2AR signaling 212. The gene discussed is CTLA4; the disease is neoplasm.